Indivior | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AstraZeneca USD 5.55B 307M 2024-12
Eli Lilly USD 2.42B 324.7M 2024-12
Glaxosmithkline GBP 2.7B 632M 2024-12
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Indivior 133M 11M 2024-09
J&J USD 6.45B 975M 2024-12
Kyowa Hakko Kirin JPY 40.38B 2.68B 2024-09
Merck USD 2.85B 148M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Sanofi EUR 2.68B 26M 2024-09
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12



Indivior Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2025.